# ADC THERAPEUTICS SA (ADCT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ADCT/

- Reporting holders: 3
- Reported value: $40.3K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [DLK Investment Management, LLC](https://holderbook.com/funds/2016793-dlk-investment-management-llc/) | $37.2K | 30,467 | 0.0% | 12 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $2.9K | 2,348 | 0.0% | 4 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $303 | 248 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $40.3K |
| Q2 2026 | 115 | $104.4M |
| Q1 2026 | 119 | $314.6M |
| Q4 2025 | 115 | $293.0M |
| Q3 2025 | 106 | $270.5M |
| Q2 2025 | 86 | $180.8M |
| Q1 2025 | 81 | $76.2M |
| Q4 2024 | 84 | $112.6M |
| Q3 2024 | 77 | $170.8M |
| Q2 2024 | 74 | $165.1M |
| Q1 2024 | 38 | $181.4M |
| Q4 2023 | 38 | $57.7M |